Company profile: Inkemia
1.1 - Company Overview
Company description
- Provider of high technological value knowledge generation, management and exploitation to support industries in the field of life sciences, focusing on creating and leveraging knowledge rather than being an industrial company.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Inkemia
Amador Bioscience
HQ: United States
Website
- Description: Provider of translational sciences, clinical pharmacology, bioanalysis, biomarker, and clinical research services to biopharmaceutical companies to support drug development. Offerings include immunoassays and cell-based assays for biomarkers and anti-drug antibodies, biometrics and pharmacometrics, regulatory affairs, and support for global clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amador Bioscience company profile →
ANMI
HQ: Belgium
Website
- Description: Provider of innovative radiopharmaceutical solutions, developing radiometals labeled theranostic radiopharmaceuticals and delivering global services in the nuclear medicine and radiopharmaceutical fields, including solutions that facilitate scalable synthesis; based in Liège, Belgium.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ANMI company profile →
Mikart
HQ: United States
Website
- Description: Provider of integrated CDMO services, technology and support for the development, manufacturing and packaging of solid dose and non-sterile liquid pharmaceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mikart company profile →
Cerbios
HQ: Switzerland
Website
- Description: Provider of chemical and biological active pharmaceutical ingredients (APIs), including high-potency APIs (HPAPIs) and antibody-drug conjugates (ADCs), with manufacturing and development capabilities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cerbios company profile →
Trilogy Writing & Consulting
HQ: Germany
Website
- Description: Provider of medical writing consultancy delivering planning, coordination, and writing of clinical and regulatory documentation for clinical development programs, including briefing books, Risk Management Plans (RMPs), Clinical Development Plans (CDPs), and Clinical Study Protocols (CSPs), ensuring cohesive communication and adherence to industry standards.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trilogy Writing & Consulting company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Inkemia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Inkemia
2.2 - Growth funds investing in similar companies to Inkemia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Inkemia
4.2 - Public trading comparable groups for Inkemia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →